PRWA
Platte River Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $403K | Hold |
383
| – | – | 0.11% | 72 |
|
2024
Q2 | $403K | Hold |
383
| – | – | 0.11% | 70 |
|
2024
Q1 | $369K | Hold |
383
| – | – | 0.11% | 76 |
|
2023
Q4 | $336K | Sell |
383
-5
| -1% | -$4.39K | 0.11% | 82 |
|
2023
Q3 | $319K | Hold |
388
| – | – | 0.12% | 79 |
|
2023
Q2 | $279K | Hold |
388
| – | – | 0.1% | 84 |
|
2023
Q1 | $319K | Hold |
388
| – | – | 0.12% | 74 |
|
2022
Q4 | $280K | Hold |
388
| – | – | 0.12% | 77 |
|
2022
Q3 | $267K | Hold |
388
| – | – | 0.12% | 77 |
|
2022
Q2 | $229K | Hold |
388
| – | – | 0.1% | 80 |
|
2022
Q1 | $271K | Hold |
388
| – | – | 0.1% | 78 |
|
2021
Q4 | $243K | Sell |
388
-160
| -29% | -$100K | 0.08% | 81 |
|
2021
Q3 | $332K | Buy |
548
+172
| +46% | +$104K | 0.12% | 75 |
|
2021
Q2 | $210K | Buy |
+376
| New | +$210K | 0.08% | 87 |
|
2020
Q3 | – | Sell |
-472
| Closed | -$296K | – | 87 |
|
2020
Q2 | $296K | Buy |
+472
| New | +$296K | 0.16% | 76 |
|